Baylis Medical: Innovating the RF Transseptal System to Global Impact
February 11 @ 12:00 pm - 1:00 pm EST
Speaker
Kris Shah
President
Baylis Medical Technologies
Abstract
Baylis Medical has been innovating medical devices globally for over 25 years. This presentation highlights the journey of the RF Transseptal System, used for percutaneous access to the left atrium, from concept to becoming a global standard of care, treating over 2 million patients in 30+ countries. Acquired by Boston Scientific for $1.75 billion USD in 2022, the system exemplifies engineering-driven healthcare innovation. Key milestones, challenges, and lessons learned from clinical, engineering, and entrepreneurial perspectives will be shared. Time will be reserved for audience Q&A.
